Minneapolis, Minnesota, USA
June 10, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the new Genedata Expressionist for Mass Spectrometry will be showcased at the 61st ASMS Conference on Mass Spectrometry. Compatible with data formats of all major MS vendors, Genedata Expressionist software significantly improves MS lab productivity. It provides an enterprise-level, integrated, and automated data analysis platform, which covers major biopharmaceutical applications including: characterization of post-translational modifications; glycosylation studies; mass analysis of intact proteins; and host cell protein analysis. During ASMS 2013, Genedata will preview the latest version of Genedata Expressionist at the Minneapolis Convention Center (June 10-13; Booth #46) and at the Rochester Hospitality Suite at the Hilton Minneapolis Hotel (June 10-12; 8pm - 11pm).

Data Processing Time Reduced from Weeks to Hours

Genedata Expressionist for Mass Spectrometry standardizes and automates the analysis of massive mass spectrometry datasets while offering state-of-the-art algorithms for high quality results. "We have implemented Genedata Expressionist for key parts of our workflow in biotherapeutics stability assessment and have successfully removed a major data analysis bottleneck," noted a senior scientist at Janssen R&D. "What previously took us a month of work, we do now within a day. And, Expressionist's excellent data visualization tools help to simplify our decision-making processes."

"We are excited and encouraged by the market adoption of Genedata Expressionist for Mass Spectrometry, which effectively addresses a data analysis bottleneck for our customers," said Dr. Othmar Pfannes, CEO of Genedata. "We are committed to advancing Genedata Expressionist as the vendor-agnostic platform of choice for MS data analysis and helping to make key processes in biopharmaceutical R&D as efficient as possible."
 

Website: http://www.genedata.com/

Published: June 11, 2013